Fact check
“Expected future revenues help determine how much companies invest in research.”
Reasoning
The evidence excerpt from Reason.com explains that companies base their research investment decisions on anticipated future revenues, and that price caps can diminish those revenues, potentially reducing research funding. This directly corroborates the claim.
On confidence: The claim is directly stated in the provided source, which explicitly links expected future revenues to company investment in research.
Important context
The source discusses pharmaceutical pricing and its impact on research investment, illustrating the broader economic principle that expected revenues influence R&D spending.
Evidence
Supporting (1)
- Tier 1 — Primary sourcePrice controls don't work. So why do many Democrats and Republicans love them?
drugs are more complicated, but the basic tradeoff remains. Reducing drug prices can benefit patients today, at least on the surface. However, developing new drugs is extraordinarily expensive and risky. Expected future revenues help…
Limitations
The assessment relies on a single source focused on the pharmaceutical industry; broader industry data or counter‑examples are not provided. No independent origin corroborated this claim, so it cannot be verified and confidence cannot be high.
- Last verified:
- Oct 8, 2026, 4:20 PM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Factual
Where this claim appeared
Price Controls Don't Work. So Why Do So Many Democrats and Republicans Love Them?Reason · Veronique de Rugy